Prostate cancer metastasis-caused osteolytic lesions, which release the space for further malignant growth in the targeted bone, are characterized by significant RANK/ RANKL/OPG signaling (Jin et al., 2011[63]). The gene discussed is TNFRSF11B; the disease is prostate cancer.